Touch Medical Imaging Software Receives US FDA Approval
Touch Medical Solutions, a wholly owned subsidiary of DMH International has received the US Food and Drug Administration approval for its medical imaging software suite, TouchPACS. The software has been approved as a Class II medical device.
“The FDA approval has allowed for the immediate marketing of our PACS software,” explained Rik J Deitsch, CEO of DMH International. “TouchPACS is now registered as a Class II medical device and can be sold to hospitals, clinics, radiology centers and physician offices for all of their imaging needs,” he said.
TouchPACS is a cutting edge software suite for the PACS medical imaging market (Picture Archiving and Communications Systems). The market was valued at approximately $2.8 billion in 2010 and it is expected to grow to over $5.4 billion by 2017, according to MarketResearch.com, a research firm based out of Rockville, Maryland.
Touch Medical Solutions, is a medical software and device company specializing in PACS (Picture Archiving and Communications Systems), EHR (Electronic Hospital records), EMR (Electronic Medical Records), PHR (Personal Health Records), Medical Transcription, and Paperless Medical Office Solutions.
- Intelerad acquires LUMEDX, expands cardiovascular expertiseTechnology & AI
- New medical image segmentation tool uses AI to reduce errorsTechnology & AI
- McKinsey: Five ways to manage pandemic-driven demandProcurement & Supply Chain
- Freshworks: delivering a 360 software solutionProcurement & Supply Chain